Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20.9M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
+795K
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$43.5M
-
Put/Call ratio
-
0.56
-
Number of buys
-
89
-
Number of sells
-
-64
-
Price
-
$42.05
Significant Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q2 2025
193 filings reported holding PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK as of Q2 2025.
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.53M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.97M shares), Cormorant Asset Management, LP (1.63M shares), BlackRock, Inc. (1.59M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.47M shares), MORGAN STANLEY (1.23M shares), VANGUARD GROUP INC (1.22M shares), Soleus Capital Management, L.P. (967K shares), Point72 Asset Management, L.P. (954K shares), and PERCEPTIVE ADVISORS LLC (753K shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.